| 54 |
Titel |
TI |
[EN] USE OF ENDOGENOUS METABOLITES FOR EARLY DIAGNOSING SEPSIS
[FR] UTILISATION DE MÉTABOLITES ENDOGÈNES POUR UN DIAGNOSTIC PRÉCOCE DE LA SEPSIE |
| 71/73 |
Anmelder/Inhaber |
PA |
BAUER MICHAEL, DE
;
BIOCRATES LIFE SCIENCES AG, AT
;
DALLMANN GUIDO, AT
;
DEIGNER HANS-PETER, DE
;
ENOT DAVID, FR
;
IGWE EMEKA, AT
;
KOAL THERESE, AT
;
KOHL MATTHIAS, DE
|
| 72 |
Erfinder |
IN |
BAUER MICHAEL, DE
;
DALLMANN GUIDO, AT
;
DEIGNER HANS-PETER, DE
;
ENOT DAVID, FR
;
IGWE EMEKA, AT
;
KOAL THERESE, AT
;
KOHL MATTHIAS, DE
|
| 22/96 |
Anmeldedatum |
AD |
22.12.2010 |
| 21 |
Anmeldenummer |
AN |
2010070544 |
|
Anmeldeland |
AC |
EP |
|
Veröffentlichungsdatum |
PUB |
07.07.2011 |
33
31
32 |
Priorität |
PRC
PRN
PRD |
EP
09180820
20091228
|
| 51 |
IPC-Hauptklasse |
ICM |
G01N 33/92
(2006.01)
|
| 51 |
IPC-Nebenklasse |
ICS |
|
|
IPC-Zusatzklasse |
ICA |
|
|
IPC-Indexklasse |
ICI |
|
|
Gemeinsame Patentklassifikation |
CPC |
G01N 2800/26
G01N 33/92
|
|
MCD-Hauptklasse |
MCM |
G01N 33/92
(2006.01)
|
|
MCD-Nebenklasse |
MCS |
|
|
MCD-Zusatzklasse |
MCA |
|
| 57 |
Zusammenfassung |
AB |
[EN] The present invention relates to a use of a plurality of endogenous target metabolites for predicting a likelihood of an onset of a sepsis from a biological sample of a mammalian subject in vitro, wherein said endogenous target metabolites have a molecular mass less than 1500 Da and are selected from the group of oxysterols.
[FR] La présente invention concerne l'utilisation d'une pluralité de métabolites cibles endogènes pour prévoir une probabilité d'apparition d'une sepsie à partir d'un échantillon biologique chez un sujet mammifère in vitro, lesdits métabolites cibles endogènes ayant une masse moléculaire inférieure à 1 500 Da et étant choisis parmi le groupe des oxystérols. |
| 56 |
Entgegengehaltene Patentdokumente/Zitate,
in Recherche ermittelt |
CT |
|
| 56 |
Entgegengehaltene Patentdokumente/Zitate,
vom Anmelder genannt |
CT |
US000005780237A
US020070111316A1
|
| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
in Recherche ermittelt |
CTNP |
"Low plasma cholesterol (CHO) in septic patients - G. Nanni, M. Pittiruti, A. Mancini, G. Sganga, D. Gui, R. Tacchino. Centro Shock, CNR, Catholic Univ., Rome, Italy" CLINICAL NUTRITION, CHURCHILL LIVINGSTONE, LONDON, GB, vol. 6, 1 August 1987 (1987-08-01), page 99, XP022963204 ISSN: 0261-5614 [retrieved on 1987-08-01] 7;
CHIARLA C ET AL: "The relationship between plasma cholesterol, amino acids and acute phase proteins in sepsis" AMINO ACIDS (VIENNA), vol. 27, no. 1, August 2004 (2004-08), pages 97-100, XP002584278 ISSN: 0939-4451 7;
MEMIS ET AL: "High C-reactive protein and low cholesterol levels are prognostic markers of survival in severe sepsis" JOURNAL OF CLINICAL ANESTHESIA, BUTTERWORTH PUBLISHERS, STONEHAM, GB LNKD- DOI:10.1016/J.JCLINANE.2006.10.008, vol. 19, no. 3, 1 May 2007 (2007-05-01), pages 186-191, XP022093314 ISSN: 0952-8180 7;
XU P B ET AL: "A metabonomic approach to early prognostic evaluation of experimental sepsis" JOURNAL OF INFECTION, ACADEMIC PRESS, LONDON, GB LNKD- DOI:10.1016/J.JINF.2008.03.011, vol. 56, no. 6, 1 June 2008 (2008-06-01), pages 474-481, XP022690620 ISSN: 0163-4453 [retrieved on 2008-05-08] 7
|
| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt |
CTNP |
'ACCP/SCCM Consensus Conference Committee (1992): Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis' CRIT CARE MED. vol. 20, no. 6, pages 864 - 874 1;
ANDERSEN ET AL.: 'Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets' CANCER RESEARCH vol. 64, 2004, pages 5245 - 5250 1;
ANNANE D; AEGERTER P; JARS-GUINCESTRE MC; GUIDET B.: 'Current epidemiology of septic shock: the CUB-Rea Network' AM J RESPIR CRIT CARE MED vol. 168, 2003, pages 165 - 72 1;
BEGER HG; RAU BM: 'Severe acute pancreatitis: Clinical course and management' WORLD J GASTROENTEROL. vol. 13, 2007, pages 5043 - 51 1;
BENJAMINI Y.; HOCHBERG Y.: 'Controlling the false discovery rate: a practical and powerful approach to multiple testing' JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B vol. 57, 1995, pages 289 - 300 1;
BERNARD GR; VINCENT JL; LATERRE PF ET AL.: 'Efficacy and safety of recombinant human activated protein C for severe sepsis' N ENGL J MED vol. 344, 2001, pages 699 - 709 1;
FERREIRA FL; BOTA DP; BROSS A ET AL.: 'Serial evaluation of the SOFA score to predict outcome in critically ill patients' JAMA vol. 286, 2002, pages 1754 - 1758 1;
G. FAMULARO ET AL. JOURNAL OF ENDOTOXIN RESEARCH vol. 2, no. 2, 1995, pages 141 - 147 1;
GRIFFITHS W. J.; WANG Y.; ALVELIUS G.; LIU S.; BODIN K.; SJ6VALL J.: 'Analysis of oxysterols by electrospray tandem mass spectrometry' J AM SOC MASS SPECTROM. vol. 17, no. 3, 2006, pages 341 - 362 1;
HASTIE T.; TIBSHIRANI R.; NARASIMHAN B.; CHU G. R PACKAGE 1;
HEALY ANNUL. PHARMACOTHER. vol. 36, 2002, pages 648 - 54 1;
HONDA A.; YAMASHITA K.; MIYAZAKI H.; SHIRAI M.; IKEGAMI T.; XU G.; NUMAZAWA M. HARA T.; MATSUZAKI Y.: 'High sensitive analysis of sterol profiles in human serum by LC-ESI-MS/MS' J. LIPID RES. vol. 49, no. 9, 2008, pages 2063 - 2073 1;
JIANG X.; ORY D. S.; HAN X.: 'Characterization of oxysterols by electrospray ionization tandem mass spectrometry after one-step derivatization with dimethylglycine' RAPID COMMUN MASS SPECTROM vol. 21, no. 2, 2007, pages 141 - 152 1;
LEVY M; FINK M; MITCHELL P; MARSHALL JC; ABRAHAM E ET AL. FOR THE INTERNATIONAL SEPSIS DEFINITIONS CONFERENCE 2001, 1;
MARSHALL JC; COOK DJ; CHRISTOU NV ET AL.: 'Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome' CRIT CARE MED vol. 23, 1995, pages 1638 - 1652 1;
PING-BO XU ET AL. JOURNAL OF INFECTION vol. 56, 2008, page 474E481 1;
R: A LANGUAGE AND ENVIRONMENT FOR STATISTICAL COMPUTING, R DEVELOPMENT CORE TEAM, R FOUNDATION FOR STATISTICAL COMPUTING,VIENNA, AUSTRIA 2009, 1;
SMYTH G.K.: 'Bioinformatics and Computational Biology Solutions using R and Bioconductor', SPRINGER article 'Limma: linear models for microarray data', pages 397 - 420 1;
SMYTH G.K.: 'Bioinformatics and Computational Biology Solutions using R and Bioconductor', SPRINGER pages 397 - 420 1;
WISHART DS ET AL.: 'HMDB: the Human Metabolome Database' NUCLEIC ACIDS RES., [Online] vol. 35, January 2007, pages D521 - 6 Retrieved from the Internet: 1
|
|
Zitierende Dokumente |
|
Dokumente ermitteln
|
|
Sequenzprotokoll |
|
|
|
Prüfstoff-IPC |
ICP |
G01N 33/92
|
